1 / 2

Systemic Scleroderma Newsletter Industry and Updated News

Systemic Scleroderma,<br>Systemic Scleroderma Newsletter, <br>Systemic Scleroderma Healthcare Newsletter,<br>Systemic Scleroderma Companies,

yashb
Download Presentation

Systemic Scleroderma Newsletter Industry and Updated News

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 1 Systemic Scleroderma Newsletter Industry & Updated News Systemic scleroderma (SSC or systemic sclerosis) is an autoimmune disorder that results into scar tissues (fibrosis) on the skin and internal organs. The prevalence of systemic scleroderma is about 30-500 cases in 1 million with more common in women than men. Know more about the disease, its causes, symptoms and diagnosis through the newsletter. DelveInsight brings to focus an autoimmune skin disorder that can be due to either or a combination of genetic and environmental factors. The Systemic Scleroderma newsletter compiles the epidemiological scenario, treatment modalities, unmet needs prevalent and the emerging therapies in the SSD Market. It also focuses on recent ongoings on the R&D front, news coverings, major pharma players involved and collaborations and funding taking place in the domain. Get the newsletter directly mailed to your email box by filling up a simple form towards your right. Join our Newsletter series and get rich insights delivered every week to you.

  2. 2 #DelveInsight, through its newsletter series, aims for increased awareness about the indication, its underlying causes, etiology, symptoms, and risk factors among its readers. Know More About What's Covered: Indication overview Signs, symptoms, and diagnosis Epidemiological trends Treatment approaches Pipeline drugs Clinical trials Top conferences Support from International organizations News Flash R&D in the field Key Companies Collaborations and deals in the domain Market insights Unmet needs Have a copy of newsletter-https://www.delveinsight.com/whitepaper- newsletter/systemic-scleroderma-newsletter #raredisease #rare #disease #medicalsciences #newsletter #promotion #covid19 #healthcare #business #systemicscleroderma #readerscommunity #readinglist #newsletterdesign

More Related